| Literature DB >> 18932067 |
Stamatia Theodoridou1, Michael Alemayehou, Nikolaos Prappas, Olga Karakasidou, Vasiliki Aletra, Eleni Plata, Panagiotis Tsaftaridis, Photini Karababa, Marina Boussiou, Klio Sinopoulou, Anna Hatzi, Ersi Voskaridou, Afroditi Loutradi, Anna Manitsa.
Abstract
Hemoglobinopathies constitute the most frequent monogenic disorders worldwide and thalassemias are the most frequent genetic disorders in Greece. Over a 5-year period (2002-2006), 1,375 couples were screened for hemoglobinopathies and counseled at our Thalassaemia Prevention Unit, Hippokration Hospital, Thessaloniki, Greece. In 148 cases (10.7%), both partners carried an abnormal hemoglobin (Hb) gene and genetic counseling was offered. One hundred out of 116 pregnancies were at-risk of giving birth to an offspring carrying either the homozygous or double heterozygous forms of the mutations under discussion. The remaining 16 pregnancies involved couples who were heterozygous for mutations that did not cause severe clinical disease, and were exempted from prenatal diagnosis. Twenty-six fetuses were found to be homozygotes or double heterozygotes for clinically significant mutations. These couples were informed of the danger of having an affected child but the termination or continuation of the pregnancy was left to the couples to decide. Nevertheless, all the couples preferred to terminate the pregnancies. The National Thalassaemia Prevention Programme has effectively decreased the incidence of thalassemia major and sickle cell syndromes in Greece.Entities:
Mesh:
Year: 2008 PMID: 18932067 DOI: 10.1080/03630260802341745
Source DB: PubMed Journal: Hemoglobin ISSN: 0363-0269 Impact factor: 0.849